The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers

Background. Value assessments and treatment decision making typically focus on clinical endpoints, especially overall survival (OS). However, OS data are not always available, and surrogate markers may also have some value to patients. This study sought to estimate preferences for progression-free s...

Descripción completa

Detalles Bibliográficos
Autores principales: MacEwan, Joanna P., Doctor, Jason, Mulligan, Karen, May, Suepattra G., Batt, Katharine, Zacker, Christopher, Lakdawalla, Darius, Goldman, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589981/
https://www.ncbi.nlm.nih.gov/pubmed/31259249
http://dx.doi.org/10.1177/2381468319855386

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6589981/
https://www.ncbi.nlm.nih.gov/pubmed/31259249
http://dx.doi.org/10.1177/2381468319855386

Ejemplares similares